22/08/2019 17:54

{I-bank focus}Goldman raises Frontage (01521) to HK$4.24

[ET Net News Agency, 22 August 2019] Goldman Sachs raised its target price for Frontage
Holdings (01521) to HK$4.24 from HK$3.71 and maintained its "buy" rating.
The research house said Frontage's earnings of US$9.3mn were above Goldman's estimates
with one-off US tax benefits, while revenue of US$49.7mn was slightly below expectations,
with softer China operation due to capacity constraints for bioanalytical services and
ramp-up of new business (e.g., DMPK).
Goldman expects China revenue to accelerate in 2H 2019/2020 with ongoing capacity
expansion in Shanghai site. US sales accelerated, driven by enhanced capability in
capturing emerging demand for biologics/biomarker BA services and turnaround of Concord.
With US$87mn backlog by 1H, Goldman sees strong earnings' visibility over the next 12
months, with potential upside from expanding service offerings. (KL)

etnet財經‧生活App   財智‧健康‧品味生活     【立即下載】  iOS版 / Android版

【etnet Bonus賞你】好好社企 中秋精選月餅禮盒

【etnet Bonus賞你】領展TKO Gateway便攜式香薰機

【etnet Bonus賞你】荃灣千色匯及元朗千色匯 x 韓國紙雕插畫藝術家Soo Min Kim 消暑手搖沙冰杯+簡約家用收納箱